ImmunoScape’s CEO interviewed by BioSpectrum Asia

Our CEO and co-founder, Choon-Peng (Choon) Ng recently spoke with BioSpectrum Asia about how our unique Deep Immunomics and machine learning platforms can discover and develop novel TCR-based therapeutics against a diverse range of tumor antigens. You can see the full feature at the link below: https://www.biospectrumasia.com/opinion/54/21778/next-generation-t-cell-receptor-tcr-therapies-can-improve-diagnosis-and-treatment-regimens.html